Original Research
Accepted on 14 May 2026
Anti-CGRP Monoclonal Antibody therapy for Migraine is not associated with early adverse bone effects: A prospective, observational, controlled, cohort study
in Headache and Neurogenic Pain
Original Research
Accepted on 14 May 2026
in Headache and Neurogenic Pain
Original Research
Accepted on 14 May 2026
in Neurotrauma
Brief Research Report
Accepted on 14 May 2026
in Cognitive Neuroscience
Original Research
Accepted on 14 May 2026
in Cognitive Neuroscience
Original Research
Published on 14 May 2026
in Hepatobiliary Diseases
Opinion
Published on 14 May 2026
in Circular Economy
Original Research
Published on 14 May 2026
in Skeletal Physiology
Original Research
Published on 14 May 2026
in Breast Cancer
Original Research
Published on 14 May 2026
in Virtual Reality in Medicine
Original Research
Published on 14 May 2026
in Cognitive Science
Original Research
Published on 14 May 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 14 May 2026
in Clinical Nutrition
Original Research
Published on 14 May 2026
in Fire and Forests
Original Research
Published on 14 May 2026
in Injury Prevention and Control
Original Research
Published on 14 May 2026
in Otology and Neurotology
Original Research
Published on 14 May 2026
in Marine Affairs and Policy